Login / Signup

2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests.

Ye ZhouLeiyu ChenTianshu JiangLiangfeng FanHang LeiYuqing WangHasiyati HeililahongJianqing MiDanxin DuTianhong MiaoRong XiaXuefeng WangDong XiangXiao-Hong CaiXiaofeng Tang
Published in: Hematology (Amsterdam, Netherlands) (2021)
2-ME-based IATs or Polybrene method could replace DTT-based IATs to mitigate DARA interference.
Keyphrases
  • multiple myeloma
  • radiation induced